aversal - FACEIT level 10, 2,057 ELO

USA
On FACEIT since 2022 88 matches tracked 31 matches in 30 days
ELO ▲ 199
2,057
30-day peak: 2,105
Rank NA ▲ 877 places
#6,795
USA #3,868 in USA
30 days · prev. #7,672 · best #5,639
Last updated:

aversal at a glance

Level 10 2,057 ELO best map Mirage (62%)
2,001-2,249 ELO

Last 20 matches compared with 2,994 players in this group: K/R above average, ADR right on the average, win rate below average.

RatingCalculated with the HLTV Rating 1.0 formula from kills, deaths and multi-kills per round. 1.00 is an average match.
better than 65%
1.08
SpreadHow much the rating swings from match to match. The smaller, the more consistent. ±0.32 ConsistencyShare of matches with a rating of 0.90 or higher. 70%
K/R
0.76
better than 59% of players
2,001-2,249 ELO avg: 0.74
Last 12 months
ADR
80.7
right on the average
2,001-2,249 ELO avg: 80.7
Last 12 months
Win rate
50%
better than 48% of players
2,001-2,249 ELO avg: 51%
Last 12 months

Facts

48 ELO Next goal ELO to the peak (2,105)
2 W · 1 L Best day +26 ELO · Nov 4, 2026
5 Comebacks last 90 days
Dust 2 Favorite map 22 of 88 matches
Mirage 62% Map pool tip weakest: Dust 2 45%
1 knife kill Rare kills last 90 days
7:00-13:00 Playing times On Wednesdays
FormMapsTiming

48 ELO away from the recorded peak (2,105). 2:1 on Nov 4, 2026 (+26 ELO, last 90 days). 5 wins after trailing at halftime (last 90 days). Most played: Dust 2 (22 of 88 matches). Strongest map: Mirage (62% win rate, 21 matches). Weakest: Dust 2 (45%, 22 matches). 1 knife kill (last 90 days). Plays most on Wednesdays between 7:00 and 13:00 (based on 88 matches).

About aversal

aversal plays CS2 on FACEIT level 10 with 2,057 ELO. The stats cover 88 matches. The strongest map is Mirage with a 62% win rate in 21 matches. Most played: Dust 2 with 22 matches and a 45% win rate. Biggest strength: Headshot rate at 61%, better than 97% of level 10 · 2,001-2,249 ELO players. aversal won 5 matches after trailing at halftime (last 90 days). Last 20 matches: 10 wins, 10 losses, -10 ELO. Previously known as aversal1.